Cara Therapeutics announces proposed offering of common stock
Cara Therapeutics announced it has commenced an underwritten public offering of shares of its common stock of up to $65 million. Cara Therapeutics expects to grant underwriters a 30-day option to purchase an additional 15% of the number of shares of common stock. July 27, 2015